Skip to main content
Login
Contact
Subscribe
Search form
Search
The Kane Republican
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
KADC
Kane Area High School
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Akari Therapeutics
(NQ:
AKTX
)
2.080
USD
-0.030 (-1.42%)
Official Closing Price
/ Updated:
5:55 PM EDT, Jul 8, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
185,200
Open
2.090
Bid (Size)
2.080 (2)
Ask (Size)
2.170 (1)
Prev. Close
2.110
Today's Range
2.038 - 2.110
52wk Range
0.8700 - 3.350
Shares Outstanding
15,256,933
Dividend Yield
N/A
Performance
YTD
+19.54%
+19.54%
1 Month
-20.31%
-20.31%
3 Month
+41.50%
+41.50%
6 Month
+17.51%
+17.51%
1 Year
+2.46%
+2.46%
Top News
More News
Akari Therapeutics Enters into a Securities Purchase Agreement for up to $30 Million with Aspire Capital Fund, LLC
July 01, 2020
from
GlobeNewswire News Releases
Akari Therapeutics Announces Appointment of Chief Financial Officer
July 01, 2020
from
GlobeNewswire News Releases
More News
Read More
Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
May 29, 2020
from
GlobeNewswire News Releases
Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid
May 21, 2020
from
GlobeNewswire News Releases
Looking To Buy Penny Stocks Right Now? 3 To Watch
June 07, 2020
from
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Akari Therapeutics to Participate in STRH Life Sciences Virtual Meeting Series
May 04, 2020
from
GlobeNewswire News Releases
Akari Therapeutics Announces Positive Topline Results from Fully Recruited Phase II Study of Nomacopan in Bullous Pemphigoid Patients
May 01, 2020
from
GlobeNewswire News Releases
Akari Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
March 31, 2020
from
GlobeNewswire News Releases
Akari Therapeutics, Plc Announces Closing of $9.5 Million Private Placement
March 04, 2020
from
GlobeNewswire News Releases
Akari Therapeutics, Plc Announces Private Placement
February 20, 2020
from
GlobeNewswire News Releases
Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment
January 27, 2020
from
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
